CureVac N.V. (CVAC)
CureVac N.V. is a clinical-stage biopharmaceutical company focused on developing transformative medicines based on messenger RNA (mRNA) technology. Its pipeline targets infectious diseases and cancer, with innovation in RNA optimization and delivery systems fueling growth. Strategic collaborations also enhance its development capacity. Chart
Verona Pharma plc (VRNA)
Verona Pharma plc is a biopharmaceutical firm advancing therapies for respiratory diseases, with a key focus on COPD. Its lead candidate, ensifentrine, is a dual-mode bronchodilator and anti-inflammatory treatment. Ongoing Phase 3 trials and regulatory momentum position it strongly for commercial success. Chart